Sign in
CompletedNo phase

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Key facts

Who runs it
University of Vermont
Where
Baltimore and Burlington, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
326 people enrolled
Started
18 Oct 2020
Ended
27 Nov 2023
Type of study
Interventional, 4 groups
Treatments tested
  • Varying the nicotine content of cigarettes
  • E-Cigarettes
Record updated
18 March 2025

Who can take part

Age
21 years to 44 years
Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Female
  • 21 to 44 years old

Who cannot take part

  • Under 21 years old
  • Over 44 years old
  • Male

Where in United States

  • Johns Hopkins UniversityBaltimore, United States
  • University of VermontBurlington, United States

About the trial

What the trial wants to find out

Despite marked reductions in cigarette smoking in the general population, smoking among economically disadvantaged women has increased. Smoking among women of reproductive age is a particular concern because in addition to the usual health risks, there are additional risks should they become pregnant. A national nicotine reduction policy for cigarettes has considerable potential to reduce tobacco use, dependence, and improve health in this population. Controlled trials in general population samples have demonstrated that reducing the nicotine content in cigarettes can reduce cigarettes per day (CPD), dependence severity, and tobacco toxicant exposure.

Read full original descriptionShow less

The goal of the proposed trial is to experimentally examine whether increasing the availability and appeal of an alternative, non-combusted source of nicotine (e-cigarettes) enhances the effect of altering the nicotine in cigarettes in non-pregnant female cigarette smokers of childbearing age. Additionally, investigators will test whether allowing participants to personalize the flavor of the e-liquid alters any moderating effects their availability may have on tobacco cigarette smoking.

Daily smokers who are female, aged 21-44 years, and have a maximum educational attainment of graduating high school, will be recruited at Johns Hopkins University and the University of Vermont.

Investigators will study two research cigarettes referred to here as Research Cigarettes 1 (RC1) and Research Cigarettes 2 (RC2). One will be a normal nicotine content cigarette and the other a reduced nicotine content cigarette. Investigators will study two e-cigarette conditions referred to here as E-Cigarette Condition 1 (EC1) and E-Cigarette Condition 2 (EC2). Both e-cigarette conditions will involve the same commercially available devices and same nicotine-containing e-liquid, but in one condition that e-liquid will be available only in tobacco flavor while in the other the e-liquid will be available in multiple flavors from which participants can choose three based on personal preference. Participants will be assigned to one of the following four conditions: (1) RC1 only; (2) RC2 only; (3) RC2 + EC1; (4) RC2 + EC2.

Participants will be asked to use only their assigned study products for 16 weeks. Outcome measures include total CPD, craving, withdrawal, psychiatric symptoms, breath carbon monoxide (CO), other biomarkers of tobacco toxicant exposure, and cigarette demand assessed by behavioral economic purchase tasks.

The 4 groups in the trial

  • RC 1 onlyTreatment being tested

    Research cigarettes #1

    Treatment: Varying the nicotine content of cigarettes

  • RC 2 onlyTreatment being tested

    Research Cigarettes #2

    Treatment: Varying the nicotine content of cigarettes

  • RC 2 + EC 1Treatment being tested

    Research Cigarettes #2 plus E-cigarettes #1

    Treatment: Varying the nicotine content of cigarettes and E-Cigarettes

  • RC 2 + EC 2Treatment being tested

    Research Cigarettes #2 plus E-cigarettes #2

    Treatment: Varying the nicotine content of cigarettes and E-Cigarettes

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
18 March 2025